News | Artificial Intelligence | April 18, 2019

FocalNet artificial neural network achieves 80.5 percent accuracy in reading MRI scans for prostate cancer, compared to 83.9 percent for experienced radiologists

Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer

April 18, 2019 — University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to help radiologists improve their ability to diagnose prostate cancer. The system, called FocalNet, helps identify and predict the aggressiveness of the disease by evaluating magnetic resonance imaging (MRI) scans, and it does so with nearly the same level of accuracy as experienced radiologists. In tests, FocalNet was 80.5 percent accurate in reading MRIs, while radiologists with at least 10 years of experience were 83.9 percent accurate.

Radiologists use MRI to detect and assess the aggressiveness of malignant prostate tumors. However, it typically takes practicing on thousands of scans to learn how to accurately determine whether a tumor is cancerous or benign, and to accurately estimate the grade of the cancer. In addition, many hospitals do not have the resources to implement the highly specialized training required for detecting cancer from MRIs.

FocalNet is an artificial neural network that uses an algorithm that comprises more than a million trainable variables; it was developed by the UCLA researchers. The team trained the system by having it analyze MRI scans of 417 men with prostate cancer; scans were fed into the system so that it could learn to assess and classify tumors in a consistent way and have it compare the results to the actual pathology specimen. Researchers compared the artificial intelligence system’s results with readings by UCLA radiologists who had more than 10 years of experience.

The research suggests that an artificial intelligence system could save time and potentially provide diagnostic guidance to less-experienced radiologists.

The study’s senior authors are Kyung Sung, assistant professor of radiology at the David Geffen School of Medicine at UCLA; Steven Raman, M.D., a UCLA clinical professor of radiology and a member of the UCLA Jonsson Comprehensive Cancer Center; and Dieter Enzmann, M.D., chair of radiology at UCLA. The lead author is Ruiming Cao, a UCLA graduate student. Other authors are Amirhossein Bajgiran, Sohrab Mirak, Sepideh Shakeri and Xinran Zhong, all from UCLA.

The research is published in IEEE Transactions on Medical Imaging,1 and was presented at the IEEE International Symposium on Biomedical Imaging (ISBI), April 8-11 in Venice, Italy, where it was selected as the runner up-for best paper.

For more information: www.ieeexplore.ieee.org

 

Reference

1. Cao R., Bajgiran A.M., Mirak S.A., et al. Joint Prostate Cancer Detection and Gleason Score Prediction in mp-MRI via FocalNet. IEEE Transactions on Medical Imaging, published online Feb. 27, 2019. DOI: 10.1109/TMI.2019.2901928


Related Content

News | HIMSS

March 5, 2026 — At the Health Information and Management Systems Society (HIMSS) Conference & Exhibition 2026 in Las ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Ultrasound Women's Health

March 2, 2026 — Ultrasound AI, a provider of artificial intelligence applications for medical imaging, has received FDA ...

Time March 03, 2026
arrow
News | HIMSS

March 3, 2026 — MedDream will present its cloud-native, AI-ready universal DICOM viewer in the Amazon Web Services (AWS) ...

Time March 03, 2026
arrow
News

Feb. 26, 2026 — GE HealthCare and UCSF Health have announced a 10-year Care Alliance collaboration focused on ...

Time March 02, 2026
arrow
News | Remote Viewing Systems

Feb. 26, 2026 — DeepHealth, Inc., a provider of AI-powered health informatics and a wholly owned subsidiary of RadNet ...

Time February 27, 2026
arrow
News | FDA

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Time February 26, 2026
arrow
News | Ultrasound Imaging

Feb. 25, 2026 — GE HealthCare is introducing the next generation of LOGIQ general imaging ultrasound systems – an ...

Time February 25, 2026
arrow
News | Contrast Media

Feb. 23, 2026 — Bracco, a global leader in diagnostic imaging, recently announced that the U.S. Food and Drug ...

Time February 24, 2026
arrow
Subscribe Now